Chinese defendants seek to regain initiative in US court fights with increased IPR filings
Beijing-based medical device manufacturer BMC Medical this week touted a recent inter partes review (IPR) decision knocking out a patent that competitor ResMed has used to sue the Chinese company in the US. The two companies make masks and…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.